8/14/2025China Sees Surge in Innovative Drug Approvals in H1, Covering Cancer, ...

8/13/2025The Trends Shaping Chinese Pharma Patent Litigation (Mondaq)

8/13/2025Merck Halts NSCLC Development of MK-1308 Amid Partnership with China's...

8/13/2025Haichang Biotech Completes Nearly CNY 500M Series C Financing to Advan...

8/13/2025CTTQ Secures IND Acceptance from China's NMPA for Two Innovative Cance...

8/13/2025NHSA Publishes Preliminary Review Results for 2025 NRDL Adjustments wi...

8/13/2025Gracell Gains NMPA Approval to Advance GC012F into Light-Chain Amyloid...

8/13/2025Summit Skips Quarterly Earnings Call amid Strategic Shifts and BLA Pla...

8/13/2025MNCs Target China's New Commercial Insurance Catalog to Gain Ground

8/12/2025Kexing Biopharm Partners with IQVIA to Accelerate Global Expansion of ...

8/12/2025Akeso Doses First Patient in Phase III Trial of Ivonescimab

8/11/2025Ab&B Bio-Tech Launches IPO on HKSE

8/11/2025Ribopeutic Raises CNY 100M in Series Pre-A to Accelerate RNA-Targeting...

8/11/2025China's Innovative Drug Boom: ADC and BsAbs Drive Industry Transformat...

8/11/2025Novo Nordisk Reports Solid Growth in China Amid Global Expansion in H1...

8/11/2025Fosun Strikes Major Licensing Deal with Expedition to Develop Respirat...

8/8/2025Minghui's MHB042C Earns Green Light for Clinical Trials in Advanced So...

8/8/2025Bio-Thera Launches Ambitious Triple-Immunotherapy Trial for Advanced S...

8/8/2025AstraZeneca Expands Use of Fasenra in China

8/8/2025AsiFlyer Secures New Funding to Propel Next‑Gen Botulinum Toxin

8/8/2025Dizal's Birelentinib Granted FDA Fast Track for Treatment-Resistant CL...

8/8/2025AlphaGen Closes Series A Funding

8/8/2025Innogen Launches $87M Hong Kong IPO to Fund Trials and Launches

8/8/2025Minghui Raises $131M to Accelerate Clinical and Commercial Expansion

8/8/2025Shanghai Unveils 18 New Measures to Boost Commercial Health Insurance ...

8/8/2025Triple Squeeze Threatens China's Global Drug Push

8/8/2025Boan's Dulaglutide Biosimilar Secures NMPA Approval in China

8/8/2025Hengrui Launches Phase 3 Trial of Trastuzumab Rezetecan Combo for AGC

8/8/2025Fujian Haixi Pharma Files for Hong Kong IPO

8/8/2025​​​​​​​ExoNeuglia Raises Series A+ Funding to Advance iPSC Ther...

Page:23/806 Total number of articles:24152: [First][<<] [21] [22] [23] [24] [25] [>>] [End]